Home
EvolveImmune Therapeutics, Inc.

EvolveImmune Therapeutic... Market Share Analysis for March 2026

EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation. The EVOLVE platform tackles the treatment challenges of cancer cell resistance to current immunotherapies.

Industry: N/A

Domainevolveimmune.com

Year Founded2020

Employees51 - 200

Annual Revenue$1M - $2M

EvolveImmune Therapeutics, Inc.

EvolveImmune Therapeutics, Inc. (including company regionals)

evolveimmune.com

See more website traffic and engagement information

EvolveImmune Therapeutics, Inc. Revenue up to March 2026 is 1M - 2M

revenue generated by EvolveImmune Therapeutics, Inc. top domains

EvolveImmune Therapeutics, Inc. top domains revenue over 3 years

Revenue for EvolveImmune Therapeutics, Inc. top domains

evolveimmune.com1M - 2M

See more with Sales Intelligence

Total visits to EvolveImmune Therapeutics, Inc.'s top domains

Understand EvolveImmune Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

evolveimmune.com2.6K

See more with Sales Intelligence

Avg. visit duration in EvolveImmune Therapeutics, Inc.'s top domains

Analyze EvolveImmune Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

evolveimmune.com00:00:41

See more with Sales Intelligence

Avg. pageviews on EvolveImmune Therapeutics, Inc.'s top domains

See how EvolveImmune Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

evolveimmune.com1.65

See more with Sales Intelligence

EvolveImmune Therapeutics, Inc. top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by EvolveImmune Therapeutics, Inc.

These are the website technologies, by industry, used by EvolveImmune Therapeutics, Inc. top domains

Widget (7)

Twemoji

Content Management System (3)

WordPress

eCommerce (2)

WooCommerce

Mobile (2)

Meta Viewport

More Technologies

5

See all

News & Signals from EvolveImmune Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEvolveImmune Therapeutics, Inc. partners with Fred’s Team.Evolveimmune Therapeutics Inc. has announced a translational research collaboration with Memorial Sloan Kettering Cancer Center (MSK) to investigate the expression of a new tumor target - UL binding protein 2 (ULBP2) - in muscle-invasive bladder cancer.

NewsEvolveImmune Therapeutics, Inc. hired Kristen M. Hege as Board of Directors on Feb 11th '25.BRANFORD, Conn., Feb. 11, 2025 (GLOBE NEWSWIRE) - EvolveImmune Therapeutics, an immunotherapy company developing first-in-category, multifunctional T Cell engager biotherapeutics to address unmet medical needs in a range of solid tumors and hematological cancers, today announced the appointment of Kristen Hege, M.D., to its Board of Directors.

NewsEvolveImmune Therapeutics, Inc. is developing next-generation cancer biotherapeutics.AbbVie and EvolveImmune Therapeutics announce collaboration and option-to-license agreement to develop next-generation cancer biotherapeutics.